Editorial: MYC as a disease target beyond cancer.

1 LuoY.YangS.WuX.TakahashiS.SunL.CaiJ.et al (2021). Intestinal MYC modulates obesity-related metabolic dysfunction. Nature metabolism3, 923–939. 10.1038/s42255-021-00421-8 Summary

MYC, targeting, transcription factor, non-oncologic diseases, therapy Citation Whitfield JR (2024) Editorial: MYC as a disease target beyond cancer. Front. Cell Dev. Biol. 12:1467372. doi: 10.3389/fcell.2024.1467372 Received 19 July 2024 Accepted 31 July 2024 Published 22 August 2024 Volume 12 - 2024 Edited and reviewed by Ana Cuenda, Spanish National Research Council (CSIC), Spain Updates Copyright © 2024 Whitfield. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. *Correspondence: Jonathan R. Whitfield, [email protected] Disclaimer All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.